These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 33650675)
1. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway. Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675 [TBL] [Abstract][Full Text] [Related]
2. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway. Yang X; Yang R; Zhang Y; Shi Y; Ma M; Li F; Xie Y; Han X; Liu S Biomed Pharmacother; 2023 Sep; 165():115164. PubMed ID: 37478577 [TBL] [Abstract][Full Text] [Related]
3. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes. Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154 [TBL] [Abstract][Full Text] [Related]
4. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
5. The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin. Ma F; Song J; He M; Wang X Technol Cancer Res Treat; 2024; 23():15330338241281310. PubMed ID: 39267432 [No Abstract] [Full Text] [Related]
6. VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin. Wang Y; Zhu M; Yuan B; Zhang K; Zhong M; Yi W; Xu X; Duan X Molecules; 2018 Jan; 23(1):. PubMed ID: 29316690 [TBL] [Abstract][Full Text] [Related]
7. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-κB and Wnt/β-catenin signaling pathway. Hseu YC; Lin YC; Rajendran P; Thigarajan V; Mathew DC; Lin KY; Way TD; Liao JW; Yang HL Food Chem Toxicol; 2019 Feb; 124():219-230. PubMed ID: 30529123 [TBL] [Abstract][Full Text] [Related]
8. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells. Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970 [TBL] [Abstract][Full Text] [Related]
9. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1. Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845 [TBL] [Abstract][Full Text] [Related]
11. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis. Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782 [TBL] [Abstract][Full Text] [Related]
12. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway. Jin JQ; Han JS; Ha J; Baek HS; Lim DJ Endocrinol Metab (Seoul); 2021 Oct; 36(5):1095-1110. PubMed ID: 34645125 [TBL] [Abstract][Full Text] [Related]
13. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
14. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation. Pai JT; Chen XH; Leu YL; Weng MS Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593 [TBL] [Abstract][Full Text] [Related]
15. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related]
16. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer. Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206 [TBL] [Abstract][Full Text] [Related]
17. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate. Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641 [TBL] [Abstract][Full Text] [Related]
18. LINC01614 activated by SP1 promoted malignant behavior of triple-negative breast cancer cells via the WNT/b-Catenin signaling pathway. Chen T; Shi K; Sun S Rev Invest Clin; 2024 Oct; 76(4):185-194. PubMed ID: 39419019 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337 [TBL] [Abstract][Full Text] [Related]
20. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]